Follow Us


10 Street Name, City Name
Country, Zip Code

555-555-5555
myemail@mailservice.com

Book an Audit
Logo
Commonwealth Seed Capital Intern • May 15, 2024

AVAIL Now Supports Revit 2025, Announces New Features in Releases of Desktop Application and Revit Plugins

Lexington, Ky. (May 15, 2024) - Software company AVAIL – which creates content management system (CMS) solutions for the global architecture, engineering, and construction (AEC) industry – has released AVAIL Desktop 4.6 along with Revit plugins AVAIL for Revit 5.2 and Harvest for Revit 2.4.


Read the full article on AVAIL here.

By Commonwealth Seed Capital Intern May 6, 2024
Louisville, Ky. (May 6, 2024) – After ten years, Switcher is stepping outside the Studio! Announcing our 2024 brand refresh, some big product updates, and the future of Switcher — but first, how’d we get here?
By Commonwealth Seed Capital Intern April 30, 2024
Lexington, Ky. (April 30, 2024) – Space Tango, a leader in microgravity data analytics, biotechnology, and manufacturing; returned science samples to CubeLab customers today following the successful splashdown of SpaceX’s 30th Commercial Resupply Services (“CRS-30”) mission off the coast of Florida on April 30th.
By Commonwealth Seed Capital Intern April 9, 2024
Crestwood, Ky. (April 9, 2024) – Liberate Medical is proud to announce the successful commencement of patient enrollment in the PREVENT trial, a pivotal clinical trial examining the VentFree Respiratory Muscle Stimulator.
By Commonwealth Seed Capital Intern February 21, 2024
Chicago, Il. (February 21, 2024) – First Stop Health (FSH), a leading virtual care company for primary, urgent and mental health care needs, today announced Cole Barfield MD, MBA as the new Chief Medical Officer.
By Commonwealth Seed Capital Intern January 18, 2024
Woodbury, Minn., St. Louis, Mo., Lexington, Ky. (January 18, 2024) – Kindeva Drug Delivery (“Kindeva”), a global leader in drug-device combination products, announced today that it has acquired Summit Biosciences Inc. (“Summit”), an intranasal drug-delivery contract development and manufacturing organization (CDMO), from its founding family shareholders.
Share by: